title: Trends in Neisseria gonorrhoeae Susceptibility to Cephalosporins in the United States, 2006-2014.
authors.affiliation: Division of STD Prevention, US Centers for Disease Control and Prevention, Atlanta, Georgia.
authors.forename: Robert D
authors.initials: RD
authors.lastname: Kirkcaldy
authors.affiliation: University of Alabama, Birmingham.
authors.forename: Edward W
authors.initials: EW
authors.lastname: Hook
authors.affiliation: University of Washington, Seattle.
authors.forename: Olusegun O
authors.initials: OO
authors.lastname: Soge
authors.affiliation: Emory University, Atlanta, Georgia.
authors.forename: Carlos
authors.initials: C
authors.lastname: del Rio
authors.affiliation: Texas Department of State Health Services, Austin.
authors.forename: Grace
authors.initials: G
authors.lastname: Kubin
authors.affiliation: Johns Hopkins University, Baltimore, Maryland.
authors.forename: Jonathan M
authors.initials: JM
authors.lastname: Zenilman
authors.affiliation: Division of STD Prevention, US Centers for Disease Control and Prevention, Atlanta, Georgia.
authors.forename: John R
authors.initials: JR
authors.lastname: Papp
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002511:Cephalosporins / Q000494:pharmacology*; D024881:Drug Resistance, Bacterial; D006069:Gonorrhea / Q000188:drug therapy*; D006801:Humans; D008297:Male; D009344:Neisseria gonorrhoeae / Q000187:drug effects; D011159:Population Surveillance; D012189:Retrospective Studies; D014481:United States
chemical_list: D000900:Anti-Bacterial Agents; D002511:Cephalosporins